SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-16-759000
Filing Date
2016-11-03
Accepted
2016-11-03 17:00:20
Documents
13

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d284063ds3.htm S-3 344294
2 EX-1.2 d284063dex12.htm EX-1.2 198685
3 EX-4.4 d284063dex44.htm EX-4.4 294516
4 EX-5.1 d284063dex51.htm EX-5.1 27436
5 EX-12.1 d284063dex121.htm EX-12.1 16471
6 EX-23.1 d284063dex231.htm EX-23.1 1349
7 GRAPHIC g284063covlogo_new.jpg GRAPHIC 5142
8 GRAPHIC g284063ex51logo1.jpg GRAPHIC 4323
9 GRAPHIC g284063ex51logo2.jpg GRAPHIC 2631
10 GRAPHIC g284063suppbca_new.jpg GRAPHIC 5142
11 GRAPHIC g284063suppbcb.jpg GRAPHIC 14892
12 GRAPHIC g284063suppcovlogoa_new.jpg GRAPHIC 5142
13 GRAPHIC g284063suppcovlogob.jpg GRAPHIC 14892
  Complete submission text file 0001193125-16-759000.txt   956645
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214418 | Film No.: 161972527
SIC: 2834 Pharmaceutical Preparations